- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03989154
Primary Ovarian Insufficient Patients
Prospective Cohort Study for Primary Ovarian Insufficient Patients in Clinical Reproductive Medicine Management System/Electronic Medical Record Cohort Database (CCRM/EMRCD)
Study Overview
Status
Conditions
Detailed Description
Premature ovarian insufficiency (POI) is a rare cause of infertility in women affecting 1% of the population. It is characterized by amenorrhea, hypoestrogenism and elevated gonadotrophin levels in women younger than 40 years of age. Other than the reproductive outcome of these patients, the short- and long-term health consequences are still unknown.
Since last decade, Clinical Reproductive Medicine Management System/Electronic Medical Record Cohort Database (CCRM/EMRCD) has been used in Reproductive Medical Center, First Affiliated Hospital of Zhengzhou University, and Henan Province Key Laboratory for Reproduction and Genetics. Information of patients (POI, PCOS, Endometriosis, azoospermia, ect) were recorded comprehensively. The current project plans to recruit POI participants in our center. Biological samples, questionnaires and short/long term health data will be collected. The study is aimed to provide evidence for POI prognosis.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Lanlan Fang, M.D.
- Phone Number: 13673355291
- Email: fanglly@163.com
Study Locations
-
-
Henan
-
Zhengzhou, Henan, China, 450052
- Recruiting
- Reproductive Medical Center, First Affiliated Hospital of Zhengzhou University
-
Contact:
- Zhiqin Bu, M.D.
- Phone Number: 15981978863
- Email: rmczzu@126.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- younger than 40 years of age
- at least four or more months of amenorrhea, two or more instances in which the serum FSH level is > 40 U/L (i.e., two inspections at intervals of 1 month or more), with an oestradiol level of <20pg/ml
Exclusion Criteria:
-
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
FSH (Follicle stimulating hormone)
Time Frame: Change from Baseline FSH at each6 months
|
mIU/mL
|
Change from Baseline FSH at each6 months
|
LH (luteinizing hormone)
Time Frame: Change from Baseline LH at each6 months
|
mIU/mL
|
Change from Baseline LH at each6 months
|
Estrogen
Time Frame: Change from Baseline Estrogen at each6 months
|
pg/ml
|
Change from Baseline Estrogen at each6 months
|
Progesterone
Time Frame: Change from Baseline Progesterone at each6 months
|
ng/ml
|
Change from Baseline Progesterone at each6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Volume of uterus and ovary
Time Frame: Change from Baseline volume at each6 months
|
Record the Length (mm)*Width (mm)*Height (mm) of uterus, and each ovary
|
Change from Baseline volume at each6 months
|
Collaborators and Investigators
Publications and helpful links
General Publications
- Kovanci E, Schutt AK. Premature ovarian failure: clinical presentation and treatment. Obstet Gynecol Clin North Am. 2015 Mar;42(1):153-61. doi: 10.1016/j.ogc.2014.10.004.
- Zhai J, Yao G, Dong F, Bu Z, Cheng Y, Sato Y, Hu L, Zhang Y, Wang J, Dai S, Li J, Sun J, Hsueh AJ, Kawamura K, Sun Y. In Vitro Activation of Follicles and Fresh Tissue Auto-transplantation in Primary Ovarian Insufficiency Patients. J Clin Endocrinol Metab. 2016 Nov;101(11):4405-4412. doi: 10.1210/jc.2016-1589. Epub 2016 Aug 29.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- RMCZZU-POI cohort study
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Related
-
Baylor College of MedicineUnited States Department of Agriculture (USDA)RecruitingPregnancy Related | Healthy NutritionUnited States
-
Duke UniversityCompleted
-
Bournemouth UniversityCompletedPregnancy Related | Healthy EatingUnited Kingdom
-
Otsuka Pharmaceutical Co., Ltd.EPS CorporationCompletedHealthy | Gastric Acid-related DiseasesJapan
-
University of Texas Southwestern Medical CenterRecruitingHealthy | Stimulant Use | Stimulant-Related DisorderUnited States
-
University of Texas at AustinDriscoll Health PlanActive, not recruitingPregnancy Related | Nutrition, Healthy | Financial GiftUnited States
-
Centre Hospitalier Universitaire de Saint EtienneCompleted
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedHealthy Subjects | Pulmonary-Related Conditions | Cardiac-Related ConditionsUnited States
-
Centre Hospitalier Universitaire de Saint EtienneCompleted
-
Massachusetts General HospitalPatient-Centered Outcomes Research Institute; Vanderbilt University Medical... and other collaboratorsNot yet recruitingHealthy Aging | Health Care Utilization | Health-Related Behavior